Literature DB >> 16966555

Late-onset Tay-Sachs disease: adverse effects of medications and implications for treatment.

B E Shapiro1, S Hatters-Friedman, J A Fernandes-Filho, K Anthony, M R Natowicz.   

Abstract

The authors conducted a retrospective and brief prospective study of adverse effects of approximately 350 medications in 44 adults with late-onset Tay-Sachs disease (LOTS). Some medications were relatively safe, whereas others, particularly haloperidol, risperidone, and chlorpromazine, were associated with neurologic worsening.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16966555     DOI： 10.1212/01.wnl.0000233847.72349.b6

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  4 in total

1.  Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.

Authors:  M J Barrett; V L Shanker; W L Severt; D Raymond; S J Gross; N Schreiber-Agus; R Kornreich; L J Ozelius; S B Bressman; R Saunders-Pullman
Journal:  JIMD Rep       Date:  2014-05-22

2.  Low-dose amitriptyline-induced acute dystonia in a patient with metachromatic leukodystrophy.

Authors:  Gerarda Cappuccio; Nicola Brunetti-Pierri; Gaetano Terrone; Alfonso Romano; Generoso Andria; Ennio Del Giudice
Journal:  JIMD Rep       Date:  2012-10-30

3.  Atypical presentation of late-onset Tay-Sachs disease.

Authors:  Andres Deik; Rachel Saunders-Pullman
Journal:  Muscle Nerve       Date:  2014-02-24       Impact factor: 3.217

4.  The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.

Authors:  Camilo Toro; Mosufa Zainab; Cynthia J Tifft
Journal:  Neurosci Lett       Date:  2021-08-25       Impact factor: 3.046
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.